Fig. 2From: Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinomaEstimated a 6-month and 1-year PFS rate, and b 1- and 2-year OS rate from Cox regression based on continuous neutrophil-to-lymphocyte ratio (NLR) at week 6 (±2 weeks). NLR was modeled on the natural logarithmic scale and transformed back to the original scale for graphic presentation. PFS and OS were calculated from 6 weeks of therapyBack to article page